
Japanese firm Olympus has had decreased endoscope sales in the first nine months of its staggered fiscal year 2021/2021, according to the firm's fiscal report.
Its endoscope business leg dropped 6.5 percent to JPY 294.49m (USD 2.8m), whereas the operating result took a 16.2-percent dive to JPY 76.75m.
Already a subscriber? Log in.
Read the whole article
Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app